KANABO GROUP PLC LS-025
Research KANABO GROUP PLC LS-025 (3WD) on Bullrun: market cap EUR 316.21K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker3WD
- ExchangeF
- CountryUnited Kingdom
- SectorHealthcare
- IndustryMedical Care Facilities
- CurrencyEUR
- Market capEUR 316.21K
- Financial periodFY2023
- RevenueGBP 895.00K
- Revenue growth48.4%
- Net income-GBP 7.99M
- Free cash flow-GBP 3.05M
- Gross margin15.0%
Valuation Snapshot
latest market cap is EUR 316.21K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2023 | GBP 895.00K | -GBP 7.99M | -GBP 3.05M | 15.0% | -0.01 | GBP 1.68M | GBP 272.00K | GBP 7.51M |
| FY2022 | GBP 603.00K | -GBP 6.87M | -GBP 3.93M | 33.0% | -0.02 | GBP 3.20M | GBP 707.00K | GBP 12.45M |
| FY2021 | GBP 73.00K | -GBP 4.55M | -GBP 2.11M | 9.6% | -0.01 | GBP 4.48M | GBP 0 | GBP 5.18M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-18 | EUR 316.21K | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About KANABO GROUP PLC LS-025
Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is KANABO GROUP PLC LS-025's market cap?
KANABO GROUP PLC LS-025's market capitalization is EUR 316.21K.
What does KANABO GROUP PLC LS-025 do?
Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.